Author:
Michael Winkelman Guest Editor and Associate Editor Retired, School of Human Evolution and Social Change Arizona State University

Search for other papers by Michael Winkelman in
Current site
Google Scholar
PubMed
Close
Open access

Recent research has given new hope that psychedelics might provide important tools for treating some of our more intractable ailments. Assessment of the therapeutic applications of psychedelics for various conditions (Winkelman & Sessa, 2019) offers tantalizing promises of what may be seen as miracle cures for their immediate results and effectiveness.

As new technologies expand our understandings of the effects of these substances, we are entering a new epoch of understanding the systemic effects of psychedelics on the brain. These findings regarding the effects of psychedelics have not only opened vistas into the future, but also into the past. As we move from the misnomer of “hallucinogens” to more aptly descriptive words such as psychedelic (“mind-manifesting”) and entheogenic (“manifesting the divine within”), our views of the role of psychedelics in the past must also change. While “hallucinogen” evoked images of distorted perceptions and delusions, the “entheogenic” paradigm recasts our ancient experiences with these substances not as delusionary, but as experiences of spiritual engagement. Contemporary understandings of their effects on cognition also lead to new views of their contributions to human evolution (Winkelman, 2010, 2013, 2014, 2015).

These new paradigms of the effects of psychedelics lead to different views regarding their roles in the past. The central dilemma for these new queries is that these enigmatic substances – often characterized as drugs having debilitating effects – come front and center as key factors in the evolution of religion and cultural developments. The implications that flow from these new perspectives are paradigm shattering. The significance of their roles as “plants of the gods” has profound theological implications and forces us to ask, “Can people find god in a plant or fungi?”

The answer presented here is a resounding yes. We did and we do.

Time and again across millennia and cultures, we find clear evidence of the seminal role of psychedelics in spiritual inspiration and experience, and even in the foundations of religious traditions. When Allegro (1970) made this paradigm-shattering proposal regarding the roles of entheogens in early Christianity, he was ridiculed, mocked, character assassinated, and finally ignored.

Yet, facts have a way of persisting and even growing in their significance. The occasional outsider pointing to the entheogenic elements of religions of the past has finally given way to a growing recognition of the entheogenic pasts of not just shamanic practices, but of many religions.

The articles presented here on the entheogenic elements of religions are not merely a prod to stop and think. Here, we see the documentation of entheogenic elements, if not an entheogenic core, in the major religious traditions worldwide. These include not only the shamanic traditions, but also major world religions – Hinduism, Buddhism, Judaism, Christianity, Islam, and even Mormonism.

What are the implications for theology of these worldwide entheogenic practices? What actions should we take based on this evidence that psychedelics and the experiences that they provoke may be at the origins not just of a primordial shamanism, but also of the major world religions?

The profound implications of psychedelics for understanding humans, our nature, our evolution, and our spirituality are far beyond the scope of this issue. Our contributors here have mostly stayed with the facts rather than exploring their paradigm-shattering implications. Nonetheless, it is certain that psychology, religious studies, comparative mysticism, anthropology, evolutionary psychology, and other fields will have major shifts in their fundamental understandings of religion and spirituality and their relation to human nature once these finding have been incorporated.

And what might these implications be? What is the import of finding psychedelic plant use in the ancient core of so many religions around the world?

The entheogenic paradigm must be a psychobiological paradigm as well. The impulse to spirituality and religion was undoubtedly found time and again in the experiences of spirits generated within humans by these powerful substances. As claimed by many religious traditions, there was not just a religious impulse found in these plants, but the foundations of culture and society also emerged from the experiences produced by these substances and the enhanced perspectives provided by the profound alterations of consciousness they produced.

The implications of the cross-cultural presence of entheogenic religions are that these changes in consciousness are not simply some spiritual force as traditionally conceptualized in cultures worldwide, but also a psychobiological phenomena at the core of human nature. The recurrent patterns of psychedelic use as spiritual tools are a reflection of the specific kinds of transformations of our neurochemistry that result. We are led to the simple conclusion that such interpretations – the experience of spirits produced by ingesting special plants – are best understood not as merely a cultural belief, but as a biologically revealed truth. There are plants that have the inherent capacity to stimulate what sages across religions and centuries have told us is the perception of spiritual reality.

What modern scientists can tell us about their molecular properties and their neuropsychological effects and neurophenomenological dynamics will ultimately help us better understand the mechanisms behind the simple truth: these plants have been the source of numerous religious traditions and countless spiritual encounters and have had central contributions to the evolution of culture. Evidence indicates that human spirituality across traditions has its origins in using entheogens, such as Amanita muscaria and Psilocybe species. Our various contributions here on the entheogenic elements of religions of the past provide ample data for assertions about a common worldwide basis of religious experiences in these and other psychedelics and their influences in the formation of humanity’s religious impulses.

Our past can be seen as a pointer to a possible future as well. On one hand, religion is paradoxically a powerful tool for unifying groups, and a source of the most irreconcilable differences between peoples on the other hand. Is this the lasting legacy of our ancient spiritual foundations, differences which leave us separated from most of humanity at a most basic level? Or do entheogens lead us to a different future, one in which an embrace of entheogenic spirituality can heal wounds, religious divisions, and our disconnect from nature?

I propose that our authors here offer us such hope with a view of the numerous ways in which entheogens have united humans in the past. We have yet as humanity to embrace the possibility of profound spirituality and reconciliation via these powerful spiritual tools. In times such as now, perhaps there is no greater calling for these ancient spiritual substances.

References

  • Allegro, J. (1970). The sacred mushroom and the cross. New York, NY: Doubleday.

  • Winkelman, M. J. (2010). Shamanism: A biopsychosocial paradigm of consciousness and healing. Santa Barbara, CA: ABC-CLIO.

  • Winkelman, M. J. (2013). Shamanism and psychedelics: A biogenetic structuralist paradigm of ecopsychology. European Journal of Ecopsychology, 4, 90115.

    • Search Google Scholar
    • Export Citation
  • Winkelman, M. J. (2014). Evolutionary views of entheogenic consciousness. In J. H. Ellens (Ed.), Seeking the sacred with psychoactive substances: Chemical paths to spirituality and god (Vol. 1, pp. 341364). Santa Barbara, CA: Praeger/ABC-CLIO.

    • Search Google Scholar
    • Export Citation
  • Winkelman, M. J. (2015). Shamanism as a biogenetic structural paradigm for humans’ evolved social psychology. Psychology of Religion and Spirituality, 7(4), 267277. doi:10.1037/rel0000034

    • Search Google Scholar
    • Export Citation
  • Winkelman, M. J., & Sessa, B. (Eds.). (2019). Advances in psychedelic medicine. Santa Barbara, CA: ABC-CLIO.

  • Allegro, J. (1970). The sacred mushroom and the cross. New York, NY: Doubleday.

  • Winkelman, M. J. (2010). Shamanism: A biopsychosocial paradigm of consciousness and healing. Santa Barbara, CA: ABC-CLIO.

  • Winkelman, M. J. (2013). Shamanism and psychedelics: A biogenetic structuralist paradigm of ecopsychology. European Journal of Ecopsychology, 4, 90115.

    • Search Google Scholar
    • Export Citation
  • Winkelman, M. J. (2014). Evolutionary views of entheogenic consciousness. In J. H. Ellens (Ed.), Seeking the sacred with psychoactive substances: Chemical paths to spirituality and god (Vol. 1, pp. 341364). Santa Barbara, CA: Praeger/ABC-CLIO.

    • Search Google Scholar
    • Export Citation
  • Winkelman, M. J. (2015). Shamanism as a biogenetic structural paradigm for humans’ evolved social psychology. Psychology of Religion and Spirituality, 7(4), 267277. doi:10.1037/rel0000034

    • Search Google Scholar
    • Export Citation
  • Winkelman, M. J., & Sessa, B. (Eds.). (2019). Advances in psychedelic medicine. Santa Barbara, CA: ABC-CLIO.

  • Collapse
  • Expand

Editor-in-Chief:

Attila Szabo - University of Oslo

E-mail address: attilasci@gmail.com

Managing Editor:

Zsófia Földvári, Oslo University Hospital

 

Associate Editors:

  • Alan K. Davis - The Ohio State University & Johns Hopkins University, USA
  • Alexander De Foe, School of Educational Psychology and Counselling, Monash University, Australia
  • Zsolt Demetrovics - Eötvös Loránd University, Budapest, Hungary
  • Ede Frecska, founding Editor-in-Chief - University of Debrecen, Debrecen, Hungary
  • David Luke - University of Greenwich, London, UK
  • Dennis J. McKenna- Heffter Research Institute, St. Paul, USA
  • Jeremy Narby - Swiss NGO Nouvelle Planète, Lausanne, Switzerland
  • Stephen Szára - Retired from National Institute on Drug Abuse, Bethesda, USA
  • Enzo Tagliazucchi - Latin American Brain Health Institute, Santiago, Chile, and University of Buenos Aires, Argentina
  • Michael Winkelman - Retired from Arizona State University, Tempe, USA 

Book Reviews Editor:

Michael Winkelman - Retired from Arizona State University, Tempe, USA

Editorial Board

  • Gábor Andrássy - University of Debrecen, Debrecen, Hungary
  • Paulo Barbosa - State University of Santa Cruz, Bahia, Brazil
  • Michael Bogenschutz - New York University School of Medicine, New York, NY, USA
  • Petra Bokor - University of Pécs, Pécs, Hungary
  • Jose Bouso - Autonomous University of Madrid, Madrid, Spain
  • Zoltán Brys - Multidisciplinary Soc. for the Research of Psychedelics, Budapest, Hungary
  • Susana Bustos - California Institute of Integral Studies San Francisco, USA
  • Robin Carhart-Harris - Imperial College, London, UK
  • Per Carlbring - Stockholm University, Sweden
  • Valerie Curran - University College London, London, UK
  • Alicia Danforth - Harbor-UCLA Medical Center, Los Angeles, USA
  • Rick Doblin - Boston, USA
  • Rafael G. dos Santos - University of Sao Paulo, Sao Paulo, Brazil
  • Genis Ona Esteve - Rovira i Virgili University, Spain
  • Silvia Fernandez-Campos
  • Zsófia Földvári - Oslo University Hospital, Oslo, Norway
  • Andrew Gallimore - University of Cambridge, Cambridge, UK
  • Neal Goldsmith - private practice, New York, NY, USA
  • Charles Grob - Harbor-UCLA Medical Center, Los Angeles, CA, USA
  • Stanislav Grof - California Institute of Integral Studies, San Francisco, CA, USA
  • Karen Grue - private practice, Copenhagen, Denmark
  • Jiri Horacek - Charles University, Prague, Czech Republic
  • Lajos Horváth - University of Debrecen, Debrecen, Hungary
  • Robert Jesse - Johns Hopkins University School of Medicine, Baltimore, MD, USA
  • Matthew Johnson - Johns Hopkins University School of Medicine, Baltimore, MD, USA
  • Eli Kolp - Kolp Institute New, Port Richey, FL, USA
  • Stanley Krippner - Saybrook University, Oakland, CA, USA
  • Evgeny Krupitsky - St. Petersburg State Pavlov Medical University, St. Petersburg, Russia
  • Rafael Lancelotta - Innate Path, Lakewood, CO, USA
  • Anja Loizaga-Velder - National Autonomous University of Mexico, Mexico City, Mexico
  • Luis Luna - Wasiwaska Research Center, Florianópolis, Brazil
  • Katherine MacClean - Johns Hopkins University School of Medicine, Baltimore, MD, USA
  • Deborah Mash - University of Miami School of Medicine, Miami, USA
  • Friedericke Meckel - private practice, Zurich, Switzerland
  • Ralph Metzner - California Institute of Integral Studies, San Francisco, CA, USA
  • Michael Mithoefer - private practice, Charleston, SC, USA
  • Levente Móró - University of Turku, Turku, Finland
  • David Nichols - Purdue University, West Lafayette, IN, USA
  • David Nutt - Imperial College, London, UK
  • Torsten Passie - Hannover Medical School, Hannover, Germany
  • Janis Phelps - California Institute of Integral Studies, San Francisco, CA, USA
  • József Rácz - Semmelweis University, Budapest, Hungary
  • Christian Rätsch - University of California, Los Angeles, Los Angeles, CA, USA
  • Sidarta Ribeiro - Federal University of Rio Grande do Norte, Natal, Brazil
  • William Richards - Johns Hopkins School of Medicine, Baltimore, MD, USA
  • Stephen Ross - New York University, New York, NY, USA
  • Brian Rush - University of Toronto, Toronto, Canada
  • Eduardo Schenberg - Federal University of São Paulo, São Paulo, Brazil
  • Ben Sessa - Cardiff University School of Medicine, Cardiff, UK
  • Lowan H. Stewart - Santa Fe Ketamine Clinic, NM, USA (Medical Director)
  • Rebecca Stone - Emory University, Atlanta, GA, USA
  • Rick Strassman - University of New Mexico School of Medicine, Albuquerque, NM, USA
  • Csaba Szummer - Károli Gáspár University of the Reformed Church, Budapest, Hungary
  • Manuel Torres - Florida International University, Miami, FL, USA
  • Luís Fernando Tófoli - University of Campinas, Campinas, Brazil State
  • Malin Uthaug - Maastricht University, Maastricht, The Netherlands
  • Julian Vayne - Norwich, UK
  • Nikki Wyrd - Norwich, UK

Attila Szabo
University of Oslo

E-mail address: attilasci@gmail.com

Indexing and Abstracting Services:

  • Web of Science ESCI
  • Biological Abstracts
  • BIOSIS Previews
  • APA PsycInfo
  • DOAJ
  • Scopus
  • CABELLS Journalytics

2023  
Web of Science  
Journal Impact Factor 2.2
Rank by Impact Factor Q2 (Psychology, Multidisciplinary)
Journal Citation Indicator 0.89
Scopus  
CiteScore 2.5
CiteScore rank Q1 (Anthropology)
SNIP 0.553
Scimago  
SJR index 0.503
SJR Q rank Q1

Journal of Psychedelic Studies
Publication Model Gold Open Access
Submission Fee none
Article Processing Charge €990
Subscription Information Gold Open Access
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%. 
   

Journal of Psychedelic Studies
Language English
Size A4
Year of
Foundation
2016
Volumes
per Year
1
Issues
per Year
3
Founder Akadémiai Kiadó
Debreceni Egyetem
Eötvös Loránd Tudományegyetem
Károli Gáspár Református Egyetem
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
H-4032 Debrecen, Hungary Egyetem tér 1.
H-1053 Budapest, Hungary Egyetem tér 1-3.
H-1091 Budapest, Hungary Kálvin tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 2559-9283 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2024 0 11 5
May 2024 0 21 2
Jun 2024 0 47 9
Jul 2024 0 16 8
Aug 2024 0 30 11
Sep 2024 0 18 2
Oct 2024 0 3 2